OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 104 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,012,000 | -69.8% | 588,240 | -62.9% | 0.00% | -75.0% |
| Q3 2015 | $3,348,000 | -59.3% | 1,586,888 | -4.6% | 0.01% | -53.8% |
| Q2 2015 | $8,235,000 | -38.0% | 1,663,581 | -2.0% | 0.03% | -39.5% |
| Q1 2015 | $13,287,000 | +102.5% | 1,697,014 | +56.7% | 0.04% | +87.0% |
| Q4 2014 | $6,563,000 | +42.2% | 1,083,041 | 0.0% | 0.02% | +27.8% |
| Q3 2014 | $4,614,000 | -67.0% | 1,083,041 | -52.1% | 0.02% | -65.4% |
| Q2 2014 | $13,964,000 | -2.6% | 2,259,500 | +2.4% | 0.05% | 0.0% |
| Q1 2014 | $14,344,000 | +69.2% | 2,206,701 | +46.6% | 0.05% | +52.9% |
| Q4 2013 | $8,476,000 | +215.3% | 1,505,486 | +243.9% | 0.03% | +161.5% |
| Q3 2013 | $2,688,000 | – | 437,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |